Neu receptor dimerization

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Nature

• Publication date

  1989-06-22

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/339587A0PMID 2567498
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A point mutation in the neu oncogene mimics ligand induction of receptor aggregation

  1989cited by this paper
• Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes.

  1989cited by this paper
• The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.

  1988cited by this paper
• Ligand-induced stimulation of epidermal growth factor receptor mutants with altered transmembrane regions.

  1988cited by this paper
• Oncogenic activation of the neu‐encoded receptor protein by point mutation and deletion.

  1988cited by this paper
• Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene

  1988cited by this paper
• Leukocytes express a novel gene encoding a putative transmembrane protein-kinase devoid of an extracellular domain

  1988cited by this paper
• Helix to helix packing in proteins.

  1981cited by this paper

• Structural Aspects of Protein–Protein Interactions

  2021cites this paper
• Membrane receptor activation mechanisms and transmembrane peptide tools to elucidate them

  2019cites this paper
• Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations.

  2018cites this paper
• Parallels and Distinctions in FGFR, VEGFR, and EGFR Mechanisms of Transmembrane Signaling.

  2017cites this paper
• The growing story of (ARABIDOPSIS) CRINKLY 4.

  2016cites this paper
• The growing story of ( ARABIDOPSIS ) CRINKLY 4 1 2

  2016cites this paper
• Regulation of Cell Proliferation by Receptor Tyrosine Protein Kinases

  2015cites this paper
• Coupling Across Plasma Membrane in Ac vation of the EGF receptor ' ' ' *

  2014cites this paper
• Sequence dependent lipid-mediated effects modulate the dimerization of ErbB2 and its associative mutants.

  2013cites this paper
• Architecture and membrane interactions of the EGF receptor.

  2013cites this paper
• Endocytosis of EGFR requires its kinase activity and N-terminal transmembrane dimerization motif

  2013cites this paper
• Conformational coupling across the plasma membrane in activation of the EGF receptor.

  2013cites this paper
• Growth factor signaling in metastasis: current understanding and future opportunities

  2012cites this paper
• GxxxG motifs, phenylalanine, and cholesterol guide the self-association of transmembrane domains of ErbB2 receptors.

  2011cites this paper
• Regulation of the catalytic activity of the EGF receptor.

  2011cites this paper
• "ErbB2 signaling in breast cancer": "the role of ErbB, Akt and ShcA phosphorylation"

  2011cites this paper
• Sequence-dependent oligomerization of the Neu transmembrane domain suggests inhibition of "conformational switching" by an oncogenic mutant.

  2010cites this paper
• The effect of hydrophilic substitutions and anionic lipids upon the transverse positioning of the transmembrane helix of the ErbB2 (neu) protein incorporated into model membrane vesicles.

  2010cites this paper
• FGFR3 mutational status and protein expression in patients with bladder cancer in a Jordanian population.

  2010cites this paper
• Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment.

  2009cites this paper
• Sequence to topography relationship in membrane-inserted hydrophobic helices

  2007cites this paper
• A dimerization hierarchy in the transmembrane domains of the HER receptor family.

  2007cites this paper
• The potential role of the EGFR/ERBB2 heterodimer in breast cancer

  2007cites this paper
• Has the code for protein translocation been broken?

  2006cites this paper
• Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia

  2006cites this paper
• Systematic molecular dynamics searching in a lipid bilayer: application to the glycophorin A and oncogenic ErbB-2 transmembrane domains.

  2006cites this paper
• The transmembrane domain of the oncogenic mutant ErbB-2 receptor: a structure obtained from site-specific infrared dichroism and molecular dynamics.

  2006cites this paper
• Transgenic mouse models of breast cancer

  2005cites this paper
• The transmembrane domains of ErbB receptors do not dimerize strongly in micelles.

  2005cites this paper
• A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer

  2005cites this paper
• The epidermal growth factor receptor family.

  2005cites this paper
• An Automatic Method for Predicting Transmembrane Protein Structures Using Cryo-em and Evolutionary Data

  2004cites this paper
• Structural model for an AxxxG-mediated dimer of surfactant-associated protein C.

  2004cites this paper
• An automatic method for predicting transmembrane protein structures using cryo-EM and evolutionary data.

  2004cites this paper
• Molecular Dynamics Simulations of the Transmembrane Domain of the Oncogenic ErbB2 Receptor Dimer in a DMPC Bilayer

  2003cites this paper
• Overexpression, purification, and structural analysis of the hydrophobic E5 protein from human papillomavirus type 16.

  2003cites this paper
• Molecular dynamics simulations of the E1/E2 transmembrane domain of the Semliki Forest virus.

  2003cites this paper
• Signalling Pathways Operated by Receptor Protein Tyrosine Kinases

  2002cites this paper
• Identification of a Region within the ErbB2/HER2 Intracellular Domain That Is Necessary for Ligand-independent Association*

  2002cites this paper
• A putative molecular-activation switch in the transmembrane domain of erbB2

  2002cites this paper
• The Single Transmembrane Domains of ErbB Receptors Self-associate in Cell Membranes*

  2002cites this paper
• Interaction between ErbB‐1 and ErbB‐2 transmembrane domains in bilayer membranes

  2002cites this paper
• Dimer Interface of Transmembrane Domains for neu/erbB-2 Receptor Dimerization and Transforming Activation: a Model Revealed by Molecular Dynamics Simulations

  2001cites this paper
• Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain.

  2001cites this paper
• Development of Herceptin

  2000cites this paper
• Structure prediction of the dimeric neu/ErbB-2 transmembrane domain from multi-nanosecond molecular dynamics simulations

  2000cites this paper
• RTK mutations and human syndromes: when good receptors turn bad

  2000cites this paper
• The Ron oncogenic activity induced by the MEN2B-like substitution overcomes the requirement for the multifunctional docking site

  2000cites this paper
• RTK mutations and human syndromeswhen good receptors turn bad.

  2000cites this paper
• A potential role for activated HER-2 in prostate cancer.

  2000cites this paper
• Expression and membrane assembly of a transmembrane region from Neu.

  2000cites this paper
• A model for assembly and activation of the GM-CSF, IL-3 and IL-5 receptors: insights from activated mutants of the common beta subunit.

  2000cites this paper
• HER2/Neu: mechanisms of dimerization/oligomerization

  2000cites this paper
• Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase.

  2000influential citation
• Helix packing in polytopic membrane proteins: role of glycine in transmembrane helix association.

  1999cites this paper
• Functional analysis of a single chain chimeric alpha/beta-granulocyte-macrophage colony-stimulating factor receptor. Importance of a glutamate residue in the transmembrane region.

  1999cites this paper
• Functional Analysis of a Single Chain Chimeric α/β-Granulocyte-Macrophage Colony-stimulating Factor Receptor

  1999cites this paper
• Immunohistochemical expression of internal and external ErbB‐2 domains in invasive breast cancer

  1999cites this paper
• Structural analysis of receptor tyrosine kinases.

  1999cites this paper
• Collagen-homology domain 1 deletion mutant of Shc suppresses transformation mediated by neu through a MAPK-independent pathway

  1999cites this paper
• Activation of Neu (ErbB-2) Mediated by Disulfide Bond-Induced Dimerization Reveals a Receptor Tyrosine Kinase Dimer Interface

  1998cites this paper
• Guidelines for membrane protein engineering derived from de novo designed model peptides.

  1998cites this paper
• Saturation mutagenesis of the beta subunit of the human granulocyte-macrophage colony-stimulating factor receptor shows clustering of constitutive mutations, activation of ERK MAP kinase and STAT pathways, and differential beta subunit tyrosine phosphorylation.

  1998cites this paper
• Sequence-related behaviour of transmembrane domains from class I receptor tyrosine kinases.

  1998cites this paper
• Oncogenic activation of the PDGF β receptor by the transmembrane domain of p185neu*

  1998cites this paper
• Chimeras of the native form or achondroplasia mutant (G375C) of human fibroblast growth factor receptor 3 induce ligand-dependent differentiation of PC12 cells

  1997cites this paper
• Three-dimensional crystallizing combined π-bonding orbitals (‘O's’ bonding) and electrical and mechanical properties of alloy metals☆

  1997cites this paper
• Three-dimensional crystallizing combined π-bonding orbitals (‘O’s' bonding) and plastic deformation by twins and dislocation☆

  1997cites this paper
• Skeletal disorders associated with fibroblast growth factor receptor mutations.

  1997cites this paper
• Insight into signal transduction: structural alterations in transmembrane helices probed by multi-1 ns molecular dynamics simulations.

  1997cites this paper
• Activation of FGF receptors by mutations in the transmembrane domain

  1997cites this paper
• Transmembrane Domain Sequence Requirements for Activation of the p185c-neu Receptor Tyrosine Kinase

  1997cites this paper
• Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation

  1997cites this paper
• FGFR activation in skeletal disorders: too much of a good thing.

  1997cites this paper
• Proteinminus signProtein Interactions: Interface Structure, Binding Thermodynamics, and Mutational Analysis.

  1997cites this paper
• Mutation associated with Crouzon syndrome causes ligand‐independent dimerization and activation of FGF receptor‐2

  1997cites this paper
• Activating mutations in cytokine receptors: implications for receptor function and role in disease.

  1997cites this paper
• Molecular modeling of c-erbB2 receptor dimerization: coiled-coil structure of wild and oncogenic transmembrane domains--stabilization by interhelical hydrogen bonds in the oncogenic form.

  1997cites this paper
• Magic angle spinning NMR spectroscopy of membrane proteins

  1996cites this paper
• Protein:protein interactions in the lipid bilayer (review).

  1996cites this paper
• Ligand-independent Activation of Fibroblast Growth Factor Receptors by Point Mutations in the Extracellular, Transmembrane, and Kinase Domains*

  1996cites this paper
• Detailed description of an alpha helix-->pi bulge transition detected by molecular dynamics simulations of the p185c-erbB2 V659G transmembrane domain.

  1996cites this paper
• Strong hydrogen bonding interactions involving a buried glutamic acid in the transmembrane sequence of the neu/erbB-2 receptor

  1996cites this paper
• A point mutation in the extracellular domain activates LET-23, the Caenorhabditis elegans epidermal growth factor receptor homolog

  1996cites this paper
• Extracellular truncations of h beta c, the common signaling subunit for interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-5, lead to ligand-independent activation.

  1996cites this paper
• Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.

  1996cites this paper
• Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.

  1996cites this paper
• Targeting and Insertion of Proteins into the Mitochondrial Outer Membrane

  1996cites this paper
• Mustard gas crosslinking of proteins through preferential alkylation of cysteines

  1996cites this paper
• Functional Replacement of Cytokine Receptor Extracellular Domains by Leucine Zippers*

  1996cites this paper
• Interacting Residues in the Extracellular Region of the Common β Subunit of the Human Granulocyte-Macrophage Colony-stimulating Factor, Interleukin (IL)-3, and IL-5 Receptors Involved in Constitutive Activation*

  1996cites this paper
• Forces and factors that contribute to the structural stability of membrane proteins.

  1995cites this paper
• Determination of helix-helix interactions in membranes by rotational resonance NMR.

  1995cites this paper
• Functions of fibroblast growth factors and their receptors.

  1995cites this paper
• Activating point mutations in the common beta subunit of the human GM‐CSF, IL‐3 and IL‐5 receptors suggest the involvement of beta subunit dimerization and cell type‐specific molecules in signalling.

  1995cites this paper
• Transmembrane domain inversion blocks ER release and insulin receptor signaling.

  1995cites this paper
• Activation of and Signal Generation by Membrane Receptors

  1995cites this paper
• Dominant-negative Mutants of Grb2 Induced Reversal of the Transformed Phenotypes Caused by the Point Mutation-activated Rat HER-2/Neu(*)

  1995cites this paper
• A common FGFR3 gene mutation in hypochondroplasia.

  1995cites this paper
• Insulin action and the insulin signaling network.

  1995cites this paper